Fu-ying Li

发表

Investigation on the oxidation of aryl oxiranylmethanols and the synthesis of 2-aryl-N-thiazolyl-oxirane-2-carboxamides as glucokinase activators

Na Ye, A. Zhang, Meng-meng Ning, 2012 .

Pharmacological Characterization of ATPM [(-)-3-Aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a Novel Mixed κ-Agonist and μ-Agonist/-Antagonist That Attenuates Morphine Antinociceptive Tolerance and Heroin Self-Administration Behavior

A. Zhang, J. Neumeyer, Yu-Jun Wang, 2009, Journal of Pharmacology and Experimental Therapeutics.

[6,7]‐Heterocycle‐Fused 14‐Hydroxymorphinan Derivatives: Design, Synthesis, and Opioid Receptor Activity

A. Zhang, Xin Xie, Jie Chen, 2009, ChemMedChem.

N-(5-substituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl) propanamides as glucokinase activators

A. Zhang, Qingzhang Zhu, Y. Leng, 2011 .

Synthesis and SAR Study of Opioid Receptor Ligands: Mono‐ and Bis‐Indolomorphinans

A. Zhang, Xin Xie, Jie Chen, 2009, Chemical biology & drug design.

Synthesis and opioid receptor activity of indolopropellanes.

A. Zhang, Xin Xie, Jie Chen, 2009, Bioorganic & medicinal chemistry letters.

Synthesis and pharmacological evaluation of 6,7-indolo/thiazolo-morphinans--further SAR of levorphanol.

J. Neumeyer, J. Bidlack, Qizheng Yao, 2007, Journal of medicinal chemistry.

Highly enantioselective hydrogenation of alpha-aryl-beta-substituted acrylic acids catalyzed by Ir-SpinPHOX.

K. Ding, Zhaobin Han, A. Zhang, 2010, Chemical communications.

Design, synthesis, and pharmacological evaluation of N-(4-mono and 4,5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators.

A. Zhang, Qingzhang Zhu, Y. Leng, 2010, Bioorganic & medicinal chemistry.

Recent advances towards the discovery of dopamine receptor ligands

A. Zhang, Fu-ying Li, Y. Kan, 2006 .

Synthesis study on marmycin A: preparation of the C3'-desmethyl analogues.

Linghua Meng, Yuanxiang Wang, W. Hu, 2009, The Journal of organic chemistry.

Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with κ agonist and μ agonist/antagonist activity.

A. Zhang, J. Neumeyer, Yu-Jun Wang, 2014, European journal of pharmacology.

Pharmacological Characterization of ATPM [( (cid:1) )-3-Amino-thiazolo[5,4- b ]- N -cyclopropylmethylmorphinan hydrochloride], a Novel Mixed (cid:1) -Agonist and (cid:2) -Agonist/-Antagonist That Attenuates Morphine Antinociceptive Tolerance and Heroin Self-Administration Behavior

A. Zhang, J. Neumeyer, Yu-Jun Wang, 2009 .

Pharmacological Characterization of ATPM [(-)-3-Aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a Novel Mixed κ-Agonist and μ-Agonist/-Antagonist That Attenuates Morphine Antinociceptive Tolerance and Heroin Self-Administration Behavior

A. Zhang, J. Neumeyer, Yu-Jun Wang, 2009, Journal of Pharmacology and Experimental Therapeutics.